178 related articles for article (PubMed ID: 12458658)
1. Defective chylomicron synthesis as a cause of delayed particle clearance in diabetes?
Phillips C; Madigan C; Owens D; Collins P; Tomkin GH
Int J Exp Diabetes Res; 2002; 3(3):171-8. PubMed ID: 12458658
[TBL] [Abstract][Full Text] [Related]
2. Intestinal rather than hepatic microsomal triglyceride transfer protein as a cause of postprandial dyslipidemia in diabetes.
Phillips C; Bennett A; Anderton K; Owens D; Collins P; White D; Tomkin GH
Metabolism; 2002 Jul; 51(7):847-52. PubMed ID: 12077729
[TBL] [Abstract][Full Text] [Related]
3. Lipid and apolipoprotein B48 transport in mesenteric lymph and the effect of hyperphagia on the clearance of chylomicron-like emulsions in insulin-deficient rats.
Martins IJ; Sainsbury AJ; Mamo JC; Redgrave TG
Diabetologia; 1994 Mar; 37(3):238-46. PubMed ID: 8174836
[TBL] [Abstract][Full Text] [Related]
4. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?
Battula SB; Fitzsimons O; Moreno S; Owens D; Collins P; Johnson A; Tomkin GH
Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025
[TBL] [Abstract][Full Text] [Related]
5. The relationship between cholesterol absorption and intestinal cholesterol synthesis in the diabetic rat model.
Gleeson A; Owens D; Collins P; Johnson A; Tomkin GH
Int J Exp Diabetes Res; 2000; 1(3):203-10. PubMed ID: 11467411
[TBL] [Abstract][Full Text] [Related]
6. The role of dietary cholesterol in the regulation of postprandial apolipoprotein B48 levels in diabetes.
Taggart C; Gibney J; Owens D; Collins P; Johnson A; Tomkin GH
Diabet Med; 1997 Dec; 14(12):1051-8. PubMed ID: 9455933
[TBL] [Abstract][Full Text] [Related]
7. Composition, removal and metabolic fate of chylomicrons derived from diabetic rats.
Levy E; Shafrir E; Ziv E; Bar-On H
Biochim Biophys Acta; 1985 May; 834(3):376-85. PubMed ID: 3995073
[TBL] [Abstract][Full Text] [Related]
8. Why does the gut choose apolipoprotein B48 but not B100 for chylomicron formation?
Lo CM; Nordskog BK; Nauli AM; Zheng S; Vonlehmden SB; Yang Q; Lee D; Swift LL; Davidson NO; Tso P
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G344-52. PubMed ID: 18006607
[TBL] [Abstract][Full Text] [Related]
9. Does pravastatin increase chylomicron remnant catabolism in postmenopausal women with type 2 diabetes mellitus?
Ng TW; Watts GF; Stuckey BG; Ching HL; Chan DC; Uchida Y; Sakai N; Yamashita S; Martins IJ; Redgrave TG; Barrett PH
Clin Endocrinol (Oxf); 2005 Dec; 63(6):650-6. PubMed ID: 16343099
[TBL] [Abstract][Full Text] [Related]
10. Improved metabolic control reduces the number of postprandial apolipoprotein B-48-containing particles in type 2 diabetes.
Phillips C; Murugasu G; Owens D; Collins P; Johnson A; Tomkin GH
Atherosclerosis; 2000 Feb; 148(2):283-91. PubMed ID: 10657563
[TBL] [Abstract][Full Text] [Related]
11. Effect of marginal zinc deficiency on the apolipoprotein-B content and size of mesenteric lymph chylomicrons in adult rats.
Koo SI; Lee CC; Norvell JE
Lipids; 1987 Dec; 22(12):1035-40. PubMed ID: 3451009
[TBL] [Abstract][Full Text] [Related]
12. The role of microsomal triglyceride transfer protein and dietary cholesterol in chylomicron production in diabetes.
Gleeson A; Anderton K; Owens D; Bennett A; Collins P; Johnson A; White D; Tomkin GH
Diabetologia; 1999 Aug; 42(8):944-8. PubMed ID: 10491754
[TBL] [Abstract][Full Text] [Related]
13. Effect of probucol on plasma clearance and organ uptake of chylomicrons and VLDLs in normal and diabetic rats.
Mamo JC; Elsegood CL; Umeda Y; Hirano T; Redgrave TG
Arterioscler Thromb; 1993 Feb; 13(2):231-9. PubMed ID: 8381300
[TBL] [Abstract][Full Text] [Related]
14. Microsomal triglyceride transfer protein: does insulin resistance play a role in the regulation of chylomicron assembly?
Phillips C; Owens D; Collins P; Tomkin GH
Atherosclerosis; 2002 Feb; 160(2):355-60. PubMed ID: 11849658
[TBL] [Abstract][Full Text] [Related]
15. Chylomicron-remnant clearance in homozygote and heterozygote Watanabe-heritable-hyperlipidaemic rabbits is defective. Lack of evidence for an independent chylomicron-remnant receptor.
Bowler A; Redgrave TG; Mamo JC
Biochem J; 1991 Jun; 276 ( Pt 2)(Pt 2):381-6. PubMed ID: 2049068
[TBL] [Abstract][Full Text] [Related]
16. Post-prandial chylomicron response may be predicted by a single measurement of plasma apolipoprotein B48 in the fasting state.
Smith D; Watts GF; Dane-Stewart C; Mamo JC
Eur J Clin Invest; 1999 Mar; 29(3):204-9. PubMed ID: 10202376
[TBL] [Abstract][Full Text] [Related]
17. Chylomicron remnant metabolism studied with a new breath test in postmenopausal women with and without type 2 diabetes mellitus.
Dane-Stewart CA; Watts GF; Barrett PH; Stuckey BG; Mamo JC; Martins IJ; Redgrave TG
Clin Endocrinol (Oxf); 2003 Apr; 58(4):415-20. PubMed ID: 12641623
[TBL] [Abstract][Full Text] [Related]
18. Postprandial apolipoprotein B100 and B48 metabolism in familial combined hyperlipidaemia before and after reduction of fasting plasma triglycerides.
Castro Cabezas M; Erkelens DW; Kock LA; De Bruin TW
Eur J Clin Invest; 1994 Oct; 24(10):669-78. PubMed ID: 7851467
[TBL] [Abstract][Full Text] [Related]
19. Chylomicron and chylomicron remnant metabolism in STZ-induced diabetic rats.
Staprans I; Pan XM; Rapp JH; Feingold KR
Diabetes; 1992 Mar; 41(3):325-33. PubMed ID: 1551492
[TBL] [Abstract][Full Text] [Related]
20. Elevated triglyceride-rich lipoproteins in diabetes. A study of apolipoprotein B-48.
Curtin A; Deegan P; Owens D; Collins P; Johnson A; Tomkin GH
Acta Diabetol; 1996 Sep; 33(3):205-10. PubMed ID: 8904926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
